Discussing the potential of RP1 in combination with Libtayo in patients with Cutaneous squamous cell carcinoma (CSCC)Ticker(s): REPL, REGN
- Senior member, chief academic officer, director of regional therapies, cutaneous oncology department at Moffitt's cancer center
- Professor of Surgery at the University of South Florida, Morsani School of Medicine.
- Research and clinical interests include the regional therapy treatment of cutaneous melanoma and non-melanoma skin cancers, soft tissue sarcomas.
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.